NASDAQ Markets
· Mar 18, 2025 11:50 PM EDT
Not market news
Clearmind Medicine Advances CMND-100 To Clinical Trials For Alcohol Use Disorder
(RTTNews) - Clearmind Medicine Inc. (CMND), a clinical-stage biotech company, has launched its Phase I/IIa clinical trial to evaluate the safety, tolerability, and pharmacokinetics of CMND-100, its novel psychedelic-derived treatment for Alcohol Use Disorder or AUD.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
